ArticleCurrent oncology (Toronto, Ont.)2021

First-Line Treatment with a Cyclin-Dependent Kinase 4/6 Inhibitor Plus an Aromatase Inhibitor for Metastatic Breast Cancer in Alberta.

Carla P Amaro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.